BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cunningham G, Samaan MA, Irving PM. Golimumab in the treatment of ulcerative colitis. Therap Adv Gastroenterol 2019;12:1756284818821266. [PMID: 30728858 DOI: 10.1177/1756284818821266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Risto A, Abdalla M, Myrelid P. Staging Pouch Surgery in Ulcerative Colitis in the Biological Era. Clin Colon Rectal Surg 2022;35:058-65. [DOI: 10.1055/s-0041-1740039] [Reference Citation Analysis]
2 Aoun R, Hanauer S. A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis. Expert Rev Gastroenterol Hepatol 2022;16:411-23. [PMID: 35400292 DOI: 10.1080/17474124.2022.2065258] [Reference Citation Analysis]
3 Falloon K, Padival R, Kurada S, Ouali SE, Rieder F. BIOLOGIC AGENTS AND SMALL MOLECULES – MECHANISM OF ACTION. Seminars in Colon and Rectal Surgery 2022. [DOI: 10.1016/j.scrs.2022.100861] [Reference Citation Analysis]
4 Mingas PD, Zdovc J, Grabnar I, Vovk T. The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases. Molecules 2021;26:1787. [PMID: 33810104 DOI: 10.3390/molecules26061787] [Reference Citation Analysis]
5 Aardoom MA, Veereman G, de Ridder L. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E2529. [PMID: 31126015 DOI: 10.3390/ijms20102529] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
6 Melendez-Gonzalez MDM, Hamad J, Sayed C. Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure. J Invest Dermatol 2021;141:2975-9. [PMID: 34097922 DOI: 10.1016/j.jid.2021.04.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]